The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma

The incidence of thyroid cancer is increasing, especially papillary thyroid carcinoma (PTC), making it currently the fastest-growing cancer among women. Reasons for this increase remain unclear, but several risk factors including radiation exposure and improved detection techniques have been suggest...

Full description

Bibliographic Details
Main Authors: Laura W. Dillon, Christine E. Lehman, Yuh-Hwa Wang
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Journal of Thyroid Research
Online Access:http://dx.doi.org/10.1155/2012/927683
id doaj-f292ab5fc7e84a6ea39021f6510539e9
record_format Article
spelling doaj-f292ab5fc7e84a6ea39021f6510539e92020-11-24T22:56:00ZengHindawi LimitedJournal of Thyroid Research2090-80672042-00722012-01-01201210.1155/2012/927683927683The Role of Fragile Sites in Sporadic Papillary Thyroid CarcinomaLaura W. Dillon0Christine E. Lehman1Yuh-Hwa Wang2Department of Biochemistry, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1016, USADepartment of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1016, USADepartment of Biochemistry, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1016, USAThe incidence of thyroid cancer is increasing, especially papillary thyroid carcinoma (PTC), making it currently the fastest-growing cancer among women. Reasons for this increase remain unclear, but several risk factors including radiation exposure and improved detection techniques have been suggested. Recently, the induction of chromosomal fragile site breakage was found to result in the formation of RET/PTC1 rearrangements, a common cause of PTC. Chromosomal fragile sites are regions of the genome with a high susceptibility to forming DNA breaks and are often associated with cancer. Exposure to a variety of external agents can induce fragile site breakage, which may account for some of the observed increase in PTC. This paper discusses the role of fragile site breakage in PTC development, external fragile site-inducing agents that may be potential risk factors for PTC, and how these factors are especially targeting women.http://dx.doi.org/10.1155/2012/927683
collection DOAJ
language English
format Article
sources DOAJ
author Laura W. Dillon
Christine E. Lehman
Yuh-Hwa Wang
spellingShingle Laura W. Dillon
Christine E. Lehman
Yuh-Hwa Wang
The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
Journal of Thyroid Research
author_facet Laura W. Dillon
Christine E. Lehman
Yuh-Hwa Wang
author_sort Laura W. Dillon
title The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
title_short The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
title_full The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
title_fullStr The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
title_full_unstemmed The Role of Fragile Sites in Sporadic Papillary Thyroid Carcinoma
title_sort role of fragile sites in sporadic papillary thyroid carcinoma
publisher Hindawi Limited
series Journal of Thyroid Research
issn 2090-8067
2042-0072
publishDate 2012-01-01
description The incidence of thyroid cancer is increasing, especially papillary thyroid carcinoma (PTC), making it currently the fastest-growing cancer among women. Reasons for this increase remain unclear, but several risk factors including radiation exposure and improved detection techniques have been suggested. Recently, the induction of chromosomal fragile site breakage was found to result in the formation of RET/PTC1 rearrangements, a common cause of PTC. Chromosomal fragile sites are regions of the genome with a high susceptibility to forming DNA breaks and are often associated with cancer. Exposure to a variety of external agents can induce fragile site breakage, which may account for some of the observed increase in PTC. This paper discusses the role of fragile site breakage in PTC development, external fragile site-inducing agents that may be potential risk factors for PTC, and how these factors are especially targeting women.
url http://dx.doi.org/10.1155/2012/927683
work_keys_str_mv AT laurawdillon theroleoffragilesitesinsporadicpapillarythyroidcarcinoma
AT christineelehman theroleoffragilesitesinsporadicpapillarythyroidcarcinoma
AT yuhhwawang theroleoffragilesitesinsporadicpapillarythyroidcarcinoma
AT laurawdillon roleoffragilesitesinsporadicpapillarythyroidcarcinoma
AT christineelehman roleoffragilesitesinsporadicpapillarythyroidcarcinoma
AT yuhhwawang roleoffragilesitesinsporadicpapillarythyroidcarcinoma
_version_ 1725655273272508416